By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Sequenom reported after the close of the market on Tuesday that total revenues for the fourth quarter rose 28 percent on higher system and consumables sales.

Sequenom Chairman and CEO Harry Hixson also said that a nearly two-year old investigation by the US Securities and Exchange Commission may be coming to an end and the agency may bring civil injunction action against the firm.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: dynamics of protein profusion and localization, melanoma classification schemes, and more.

A company says it can generate likenesses of people based on their genetic profiles.

IBM's Watson is learning how to treat leukemia as a fellow at the MD Anderson Cancer Center, according to the Washington Post.

At her blog, Sally Rockey dives into National Institutes of Health funding data.